SUSQUEHANNA INTERNATIONAL GROUP, LLP - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 105 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,355,789
+123.7%
283,638
+98.9%
0.00%
Q2 2023$606,139
-19.1%
142,621
+1.1%
0.00%
Q1 2023$748,875
+28.1%
141,031
+51.5%
0.00%
Q4 2022$584,618
-72.2%
93,092
-53.3%
0.00%
Q3 2022$2,102,000
+295.1%
199,294
+103.4%
0.00%
Q2 2022$532,000
+129.3%
97,960
+288.3%
0.00%
Q1 2022$232,000
-90.9%
25,230
-85.0%
0.00%
Q4 2021$2,536,000168,1260.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders